Cell News and Research

RSS

Experimental vaccine shows promise for patients with newly diagnosed brain tumors

An experimental vaccine developed by researchers at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute targets overactive antigens in highly aggressive brain tumors and improves length of survival in newly diagnosed patients, according to new data that was presented in a poster session at the 47th Annual Meeting of the American Society of Clinical Oncology.

17 Jun 2011

Scientists uncover how immune system responds to invading anthrax bacteria

Scientists at the University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences have uncovered how the body's immune system launches its survival response to the notorious and deadly bacterium anthrax.

17 Jun 2011

Tips for parents to protect teens from summer injuries

Summer is the season of backyard barbecues, scenic drives through the countryside and heat-easing dips in the pool. For all of its fun, though, summer is also the time when you're most likely to suffer an injury, especially if you're a teenager, said trauma surgeon Dr. Thomas Esposito of Loyola University Health System in Maywood, Ill.

17 Jun 2011

Key to remove stem cells responsible for fat expansion

Researchers may have found the key to developing a method to rid the body of stem cells responsible for driving fat expansion. According to a report in the June 16 Cell Stem Cell, a Cell Press publication, they've landed the first protein marker on the surface of those so-called adipose stromal cells (ASCs), which serve as progenitors of the cells that make up fat tissue.

17 Jun 2011

New weapon in the fight against cancer

A cancer diagnosis is not necessarily a death sentence. There are now quite a number of possibilities to treat cancer. In addition to radiotherapy and chemotherapy, so-called radionuclide treatment has also become an important component in the fight against the mutated cells. It involves injecting radioactive elements, so-called nuclides, into the patient's circulatory system.

17 Jun 2011

Elsevier announces two new biomedical applications from Molecular Connections

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced two new applications from Molecular Connections, a life science informatics company, on SciVerse Applications beta.

17 Jun 2011

Cedars-Sinai receives National Eye Institute grant to develop gene therapy for corneal disease

Cedars-Sinai stem cell researchers investigating ways to prevent eye problems in diabetic patients have been awarded a $3 million grant from the National Eye Institute to develop gene therapy in corneal stem cells to alleviate damage to corneas that can cause vision loss.

17 Jun 2011

New Australian drug shows positive response in patients with multiple myeloma blood cancer

Australian monoclonal antibody company, Immune System Therapeutics Limited (IST), today announced it would double patient recruitment in its Phase II trial for a breakthrough antibody treatment for terminal blood cancer.

16 Jun 2011

CEVEC and Catalent Pharma Solutions offer joint cell line development service

CEVEC Pharmaceuticals, the German developer of a novel, market leading human protein expression system derived from amniocytes, and Catalent Pharma Solutions, a leading global drug development and delivery solutions provider, announced today a joint commercial cell line development service for pharma and biotech customers worldwide. The offering combines the benefits of CEVEC’s human cell line, CAP-Technology, with Catalent’s unique GPEx® (Gene Product Expression) Technology to generate high expressing stable human cell lines in a much shorter timeframe than traditional methods.

16 Jun 2011

Hopkins research suggests that blood vessels and support cells may be real targets of treatment for diabetic nerve damage

Blood vessels and supporting cells appear to be pivotal partners in repairing nerves ravaged by diabetic neuropathy, and nurturing their partnership with nerve cells might make the difference between success and failure in experimental efforts to regrow damaged nerves, Johns Hopkins researchers report in a new study.

16 Jun 2011

Adaptimmune melanoma trial opening

Adaptimmune announced today that it has opened a Phase I/II, two cohort, open label clinical trial in metastatic melanoma at Washington University, St. Louis, Missouri.

16 Jun 2011

Positive results from Cubist CXA-201 and CB-183,315 Phase 2 studies for complicated intra-abdominal infections

Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced positive top-line results from the recently completed Phase 2 studies of its CXA-201 and CB-183,315 antibiotic pipeline candidates. CXA-201 was studied for the treatment of complicated intra-abdominal infections (cIAI) in adults.

16 Jun 2011

Mary Ann Liebert peer-reviewed journal publishes new clinical guidelines on hyperthyroidism

New clinical guidelines developed by an expert panel that include 100 evidence-based recommendations for optimal care of patients with hyperthyroidism and other causes of thyrotoxicosis are presented in the current issue of Thyroid, a peer-reviewed journal published by Mary Ann Liebert, Inc.

16 Jun 2011

Physicians with low ratings in offline surveys less likely to be rated online

Patients posting their opinions about doctors on online ratings websites are much less likely to discuss physicians with low perceived quality and are more prone than offline populations to exaggerate their opinions, according to a paper being presented at a healthcare conference sponsored by the Institute for Operations Research and the Management Sciences.

16 Jun 2011

Researchers reveal why anti-androgen therapy may fail in men with prostate cancer

Cancer is crafty. When one avenue driving its growth is blocked by drugs targeting that path, the malignancy often creates a detour, finding an alternative route to get around the roadblock.

16 Jun 2011

Positive results from BiondVax Multimeric-001 Phase IIa trial against influenza

BiondVax Pharmaceuticals Ltd. today announced positive results from its first Phase II clinical trial of the Multimeric-001 Universal Influenza Vaccine.

16 Jun 2011

Initial data from COMPLETE study on peripheral T-cell lymphoma presented at ICML 2011

Allos Therapeutics, Inc. today announced the presentation of initial data from COMPLETE, an international registry designed to address the urgent need for an increased understanding of the treatment patterns and outcomes for patients with peripheral T-cell lymphoma.

16 Jun 2011

Lund University professor receives Robert A. Pritzker Prize for Parkinson's research

Anders Björklund from Lund University in Sweden has been awarded the Robert A. Pritzker Prize for his many years of leadership in research on Parkinson's disease. The prize has long been an institution in American architecture and this year, for the first time, it is also being awarded to recognise cutting-edge medical research.

16 Jun 2011

UCLA researchers find new potential therapeutic target for preventing HIV

Specific types of "helper" T cells that are crucial to maintaining functioning immune systems contain an enzyme called PDI. This enzyme affects how proteins fold into specific shapes, which in turn influences how the T cells behave.

16 Jun 2011

'Cell membrane capsules' made from real living cells improve functional drug delivery

The quest for better ways of encapsulating medicine so that it can reach diseased parts of the body has led scientists to harness - for the first time - living human cells to produce natural capsules with channels for releasing drugs and diagnostic agents.

16 Jun 2011

Cell News and Research

Experimental vaccine shows promise for patients with newly diagnosed brain tumors

Scientists uncover how immune system responds to invading anthrax bacteria

Tips for parents to protect teens from summer injuries

Key to remove stem cells responsible for fat expansion

New weapon in the fight against cancer

Elsevier announces two new biomedical applications from Molecular Connections

Cedars-Sinai receives National Eye Institute grant to develop gene therapy for corneal disease

New Australian drug shows positive response in patients with multiple myeloma blood cancer

CEVEC and Catalent Pharma Solutions offer joint cell line development service

Hopkins research suggests that blood vessels and support cells may be real targets of treatment for diabetic nerve damage

Adaptimmune melanoma trial opening

Positive results from Cubist CXA-201 and CB-183,315 Phase 2 studies for complicated intra-abdominal infections

Mary Ann Liebert peer-reviewed journal publishes new clinical guidelines on hyperthyroidism

Physicians with low ratings in offline surveys less likely to be rated online

Researchers reveal why anti-androgen therapy may fail in men with prostate cancer

Positive results from BiondVax Multimeric-001 Phase IIa trial against influenza

Initial data from COMPLETE study on peripheral T-cell lymphoma presented at ICML 2011

Lund University professor receives Robert A. Pritzker Prize for Parkinson's research

UCLA researchers find new potential therapeutic target for preventing HIV

'Cell membrane capsules' made from real living cells improve functional drug delivery

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News